{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T03:43:59Z","timestamp":1780458239725,"version":"3.54.1"},"reference-count":126,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.intimp.2021.107439","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T18:07:20Z","timestamp":1611943640000},"page":"107439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Immune response scenario and vaccine development for SARS-CoV-2 infection"],"prefix":"10.1016","volume":"94","author":[{"given":"Mai H.S.","family":"Mohammad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2021.107439_b0005","unstructured":"Asia Cn. Novel Coronavirus Map 2020 [updated 12\/08\/2020. Available from: https:\/\/infographics.channelnewsasia.com\/covid-19\/map.html."},{"key":"10.1016\/j.intimp.2021.107439_b0010","unstructured":"WHO. WHO Coronavirus Disease (COVID-19) Dashboard 2020. Available from: https:\/\/covid19.who.int\/."},{"issue":"10224","key":"10.1016\/j.intimp.2021.107439_b0015","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.intimp.2021.107439_b0020","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nrmicro.2016.81","article-title":"SARS and MERS: recent insights into emerging coronaviruses","volume":"14","author":"de Wit","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"issue":"13","key":"10.1016\/j.intimp.2021.107439_b0025","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMe2002387","article-title":"Covid-19 \u2013 navigating the uncharted","volume":"382","author":"Fauci","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.intimp.2021.107439_b0030","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.immuni.2020.05.002","article-title":"Immunology of COVID-19: current state of the science","volume":"52","author":"Vabret","year":"2020","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.intimp.2021.107439_b0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3892\/ijmm.2020.4596","article-title":"Towards effective COVID19 vaccines: Updates, perspectives and challenges (Review)","volume":"46","author":"Calina","year":"2020","journal-title":"Int. J. Mol. Med."},{"issue":"84","key":"10.1016\/j.intimp.2021.107439_b0040","first-page":"1","article-title":"Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2. Signal Transduction and Targeted","volume":"5","author":"Michele Catanzaro","year":"2020","journal-title":"Therapy"},{"issue":"3","key":"10.1016\/j.intimp.2021.107439_b0045","first-page":"170","article-title":"Potential antiviral therapeutics for 2019 Novel Coronavirus","volume":"43","author":"Li","year":"2020","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi."},{"issue":"7803","key":"10.1016\/j.intimp.2021.107439_b0050","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.1038\/s41586-020-2202-3","article-title":"Author Correction: a new coronavirus associated with human respiratory disease in China","volume":"580","author":"Wu","year":"2020","journal-title":"Nature"},{"issue":"7798","key":"10.1016\/j.intimp.2021.107439_b0055","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2021.107439_b0060","article-title":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses\u2013a statement of the coronavirus study group","author":"Gorbalenya","year":"2020","journal-title":"BioRxiv."},{"key":"10.1016\/j.intimp.2021.107439_b0065","unstructured":"WHO. Naming the Coronavirus Disease (COVID-19 and the Virus That Causes it 2020. Available from: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/technical-guidance\/ naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causesit."},{"issue":"11","key":"10.1016\/j.intimp.2021.107439_b0070","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1007\/s00108-019-00671-5","article-title":"Coronaviruses as the cause of respiratory infections","volume":"60","author":"Corman","year":"2019","journal-title":"Internist (Berl)."},{"key":"10.1016\/j.intimp.2021.107439_b0075","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.3389\/fimmu.2020.01441","article-title":"Immune Response, Inflammation, and the Clinical Spectrum of COVID-19","volume":"11","author":"Garcia","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2021.107439_b0080","doi-asserted-by":"crossref","unstructured":"J.S. Mackenzie, D.W. Smith, COVID-19: a novel zoonotic disease caused by a coronavirus from China: what we know and what we don't. Microbiol Aust. 2020:MA20013.","DOI":"10.1071\/MA20013"},{"issue":"2","key":"10.1016\/j.intimp.2021.107439_b0085","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1128\/CMR.00102-14","article-title":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease","volume":"28","author":"Chan","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"issue":"4","key":"10.1016\/j.intimp.2021.107439_b0090","first-page":"281","article-title":"Cause analysis and treatment strategies of recurrence' with novel coronavirus pneumonia (covid-19) patients after discharge from hospital","volume":"43","author":"Zhou","year":"2020","journal-title":"Chin. J. Tuberc. Respir. Dis."},{"key":"10.1016\/j.intimp.2021.107439_b0095","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1146\/annurev-micro-020518-115759","article-title":"Human Coronavirus: host-pathogen interaction","volume":"73","author":"Fung","year":"2019","journal-title":"Annu. Rev. Microbiol."},{"issue":"2","key":"10.1016\/j.intimp.2021.107439_b0100","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11684-020-0754-0","article-title":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection","volume":"14","author":"Zou","year":"2020","journal-title":"Front Med."},{"issue":"7","key":"10.1016\/j.intimp.2021.107439_b0105","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00127-20","article-title":"Receptor recognition by the Novel Coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus","volume":"94","author":"Wan","year":"2020","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.intimp.2021.107439_b0110","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.intimp.2021.107439_b0115","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","article-title":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses","volume":"5","author":"Letko","year":"2020","journal-title":"Nat. Microbiol."},{"issue":"9","key":"10.1016\/j.intimp.2021.107439_b0120","doi-asserted-by":"crossref","first-page":"153097","DOI":"10.1016\/j.prp.2020.153097","article-title":"Pathologic features of COVID-19: a concise review","volume":"216","author":"Tabary","year":"2020","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.intimp.2021.107439_b0125","article-title":"Pathological changes of the spleen in ten patients with new coronavirus infection by minimally invasive autopsies","volume":"49","author":"Xu","year":"2020","journal-title":"Zhonghua Bing li xue za zhi."},{"key":"10.1016\/j.intimp.2021.107439_b0130","article-title":"Multiscale three-dimensional pathology findings of COVID-19 diseased lung using high-resolution cleared tissue microscopy","author":"Li","year":"2020","journal-title":"bioRxiv."},{"issue":"39","key":"10.1016\/j.intimp.2021.107439_b0135","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1093\/eurheartj\/ehaa664","article-title":"Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study","volume":"41","author":"Basso","year":"2020","journal-title":"Eur. Heart J."},{"issue":"10234","key":"10.1016\/j.intimp.2021.107439_b0140","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.intimp.2021.107439_b0145","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1053\/j.gastro.2020.02.055","article-title":"Evidence for gastrointestinal infection of SARS-CoV-2","volume":"158","author":"Xiao","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intimp.2021.107439_b0150","doi-asserted-by":"crossref","unstructured":"A. Sonzogni GP, M. Seghezzi, M.G. Alessio, A. Gianatti, L. Licini, P. Zerbi, L. Carsana, R. Rossi, E. Lauri, Liver and COVID 19 Infection: A Very Preliminary Lesson Learnt from Histological Post-Mortem Findings in 48 Patients, 2020.","DOI":"10.20944\/preprints202004.0438.v1"},{"key":"10.1016\/j.intimp.2021.107439_b0155","first-page":"1","article-title":"Pathological features of the novel human coronavirus disease (COVID-19): a review","volume":"35","author":"Trik","year":"2020","journal-title":"JI M Sfax."},{"issue":"1","key":"10.1016\/j.intimp.2021.107439_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-020-02166-2","article-title":"Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology","volume":"140","author":"Reichard","year":"2020","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.intimp.2021.107439_b0165","series-title":"Cellular and Molecular Immunology","author":"Abul","year":"2015"},{"key":"10.1016\/j.intimp.2021.107439_b0170","unstructured":"Control ECfDPa. Immune responses and immunity to SARS-CoV-2 2020.Available from: https:\/\/www.ecdc.europa.eu\/en\/covid-19\/latest-evidence\/immune-responses."},{"issue":"10229","key":"10.1016\/j.intimp.2021.107439_b0175","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2021.107439_b0180","first-page":"1","article-title":"Dysregulation of immune response in patients with Coronavirus 2019 (COVID-19) in Wuhan, China","author":"Qin","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"62","key":"10.1016\/j.intimp.2021.107439_b0185","article-title":"Immune dysfunction leads to mortality and organ injury in patients with COVID-19 in China: insights from ERS-COVID-19 study","volume":"5","author":"Li","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"issue":"1","key":"10.1016\/j.intimp.2021.107439_b0190","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jped.2017.03.006","article-title":"Salivary C-reactive protein, mean platelet volume and neutrophil lymphocyte ratio as diagnostic markers for neonatal sepsis","volume":"94","author":"Omran","year":"2018","journal-title":"J. Pediatr. (Rio J)."},{"issue":"4","key":"10.1016\/j.intimp.2021.107439_b0195","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1111\/crj.12723","article-title":"Salivary C-reactive protein and mean platelet volume in diagnosis of late-onset neonatal pneumonia","volume":"12","author":"Omran","year":"2018","journal-title":"Clin Respir J."},{"key":"10.1016\/j.intimp.2021.107439_b0200","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev-immunol-042718-041356","article-title":"Sensors and modulators in innate immunity","volume":"37","author":"Hur","year":"2019","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.intimp.2021.107439_b0205","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nri1732","article-title":"Immunopathogenesis of coronavirus infections","volume":"5","author":"Perlman","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2021.107439_b0210","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa410","article-title":"Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19","author":"Chu","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.intimp.2021.107439_b0215","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.intimp.2021.107439_b0220","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.cell.2011.08.015","article-title":"Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection","volume":"146","author":"Teijaro","year":"2011","journal-title":"Cell"},{"issue":"605","key":"10.1016\/j.intimp.2021.107439_b0225","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aaw1347","article-title":"TLR7 and TLR8 activate distinct pathways in monocytes during RNA virus infection","volume":"12","author":"de Marcken","year":"2019","journal-title":"Sci Signal."},{"issue":"12","key":"10.1016\/j.intimp.2021.107439_b0230","doi-asserted-by":"crossref","first-page":"e1007390","DOI":"10.1371\/journal.ppat.1007390","article-title":"Toll-like receptor 4 in acute viral infection: too much of a good thing","volume":"14","author":"Olejnik","year":"2018","journal-title":"PLoS Pathog."},{"issue":"10","key":"10.1016\/j.intimp.2021.107439_b0235","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nri910","article-title":"NF-kappaB regulation in the immune system","volume":"2","author":"Li","year":"2002","journal-title":"Nat. Rev. Immunol."},{"issue":"51","key":"10.1016\/j.intimp.2021.107439_b0240","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1038\/sj.onc.1209943","article-title":"NF-kappaB and the immune response","volume":"25","author":"Hayden","year":"2006","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.intimp.2021.107439_b0245","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1128\/JVI.02576-13","article-title":"Inhibition of NF-kappaB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival","volume":"88","author":"DeDiego","year":"2014","journal-title":"J. Virol."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2021.107439_b0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2007.02.007","article-title":"Up-regulation of IL-6 and TNF-alpha induced by SARS-coronavirus spike protein in murine macrophages via NF-kappaB pathway","volume":"128","author":"Wang","year":"2007","journal-title":"Virus Res."},{"issue":"2","key":"10.1016\/j.intimp.2021.107439_b0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000756","article-title":"Exacerbated innate host response to SARS-CoV in aged non-human primates","volume":"6","author":"Smits","year":"2010","journal-title":"PLoS Pathog"},{"issue":"51","key":"10.1016\/j.intimp.2021.107439_b0260","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.1038\/sj.onc.1209941","article-title":"Manipulation of the nuclear factor-kappaB pathway and the innate immune response by viruses","volume":"25","author":"Hiscott","year":"2006","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.intimp.2021.107439_b0265","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2217\/imt.10.67","article-title":"Anti-TNF-alpha agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls","volume":"2","author":"Silva","year":"2010","journal-title":"Immunotherapy"},{"key":"10.1016\/j.intimp.2021.107439_b0270","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev.immunol.19.1.163","article-title":"Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?","volume":"19","author":"Feldmann","year":"2001","journal-title":"Annu. Rev. Immunol."},{"issue":"22","key":"10.1016\/j.intimp.2021.107439_b0275","doi-asserted-by":"crossref","first-page":"7809","DOI":"10.1073\/pnas.0711241105","article-title":"Modulation of TNF-alpha-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-alpha production and facilitates viral entry","volume":"105","author":"Haga","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"10229","key":"10.1016\/j.intimp.2021.107439_b0280","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Puja Mehta","year":"2020","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.intimp.2021.107439_b0285","doi-asserted-by":"crossref","first-page":"105954","DOI":"10.1016\/j.ijantimicag.2020.105954","article-title":"Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality","volume":"55","author":"Zhang","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"3","key":"10.1016\/j.intimp.2021.107439_b0290","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1124\/mol.105.018481","article-title":"Janus kinase-signal transducer and activator of transcription mediates phosphatidic acid-induced interleukin (IL)-1beta and IL-6 production","volume":"69","author":"Lee","year":"2006","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2021.107439_b0295","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1182\/blood.V91.1.258","article-title":"Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line","volume":"91","author":"Biswas","year":"1998","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.intimp.2021.107439_b0300","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.4049\/jimmunol.172.9.5676","article-title":"Differential regulation of neutrophil-activating chemokines by IL-6 and its soluble receptor isoforms","volume":"172","author":"McLoughlin","year":"2004","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2021.107439_b0305","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s11596-013-1168-x","article-title":"Inhibitory effects of suppressor of cytokine signaling 3 on inflammatory cytokine expression and migration and proliferation of IL-6\/IFN-gamma-induced vascular smooth muscle cells","volume":"33","author":"Xiang","year":"2013","journal-title":"J. Huazhong Univ. Sci. Technolog. Med. Sci."},{"issue":"15","key":"10.1016\/j.intimp.2021.107439_b0310","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1111\/bph.12713","article-title":"IL-6 in diabetes and cardiovascular complications","volume":"171","author":"Qu","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.intimp.2021.107439_b0315","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1161\/01.RES.87.12.1195","article-title":"Role of NAD(P)H oxidase in angiotensin II-induced JAK\/STAT signaling and cytokine induction","volume":"87","author":"Schieffer","year":"2000","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.intimp.2021.107439_b0320","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1128\/JVI.01248-09","article-title":"Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63","volume":"84","author":"Glowacka","year":"2010","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.intimp.2021.107439_b0325","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1161\/HYPERTENSIONAHA.118.10266","article-title":"Understanding angiotensin II type 1 receptor signaling in vascular pathophysiology","volume":"71","author":"Eguchi","year":"2018","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.intimp.2021.107439_b0330","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2019.03.027","article-title":"Pleiotropy and specificity: insights from the interleukin 6 family of cytokines","volume":"50","author":"Murakami","year":"2019","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.intimp.2021.107439_b0335","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.immuni.2020.04.003","article-title":"COVID-19: a new virus, but a familiar receptor and cytokine release syndrome","volume":"52","author":"Hirano","year":"2020","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.intimp.2021.107439_b0340","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nri2974","article-title":"The outs and the ins of sphingosine-1-phosphate in immunity","volume":"11","author":"Spiegel","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2021.107439_b0345","doi-asserted-by":"crossref","first-page":"e12836","DOI":"10.1111\/cmi.12836","article-title":"Sphingosine-1-phosphate receptors and innate immunity","volume":"20","author":"Bryan","year":"2018","journal-title":"Cell. Microbiol."},{"issue":"10","key":"10.1016\/j.intimp.2021.107439_b0350","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1073\/pnas.1400593111","article-title":"Mapping the innate signaling cascade essential for cytokine storm during influenza virus infection","volume":"111","author":"Teijaro","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S .."},{"issue":"4","key":"10.1016\/j.intimp.2021.107439_b0355","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Zhe","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"10223","key":"10.1016\/j.intimp.2021.107439_b0360","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"The Lancet."},{"issue":"6","key":"10.1016\/j.intimp.2021.107439_b0365","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/nsr\/nwaa037","article-title":"Elevated plasma levels of selective cytokines in COVID-19 patients reflect viral load and lung injury","volume":"7","author":"Liu","year":"2020","journal-title":"Natl. Sci. Rev."},{"key":"10.1016\/j.intimp.2021.107439_b0370","article-title":"Gut microbiota may underlie the predisposition of healthy individuals to COVID-19","author":"Gou","year":"2020","journal-title":"MedRxiv."},{"key":"10.1016\/j.intimp.2021.107439_b0375","article-title":"Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China","author":"Shi","year":"2020","journal-title":"medRxiv."},{"issue":"1","key":"10.1016\/j.intimp.2021.107439_b0380","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41392-020-0148-4","article-title":"Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study","volume":"5","author":"Tan","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.intimp.2021.107439_b0385","article-title":"Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing","author":"Wen","year":"2020","journal-title":"medRxiv."},{"key":"10.1016\/j.intimp.2021.107439_b0390","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41591-020-0897-1","article-title":"Antibody responses to SARS-CoV-2 in patients with COVID-19","volume":"26","author":"Quan-Xin Long","year":"2020","journal-title":"Nat. Med."},{"issue":"10262","key":"10.1016\/j.intimp.2021.107439_b0395","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/S0140-6736(20)32137-1","article-title":"SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates","volume":"396","author":"Poland","year":"2020","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.intimp.2021.107439_b0400","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.intimp.2021.107439_b0405","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41392-020-00352-y","article-title":"A systematic review of SARS-CoV-2 vaccine candidates","volume":"5","author":"Dong","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"issue":"3","key":"10.1016\/j.intimp.2021.107439_b0410","doi-asserted-by":"crossref","DOI":"10.3390\/v12030254","article-title":"Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies","volume":"12","author":"Ahmed","year":"2020","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.intimp.2021.107439_b0415","article-title":"Immunoinformatics and structural analysis for identification of immunodominant epitopes in SARS-CoV-2 as potential vaccine targets","volume":"8","author":"Mukherjee","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"3","key":"10.1016\/j.intimp.2021.107439_b0420","doi-asserted-by":"crossref","first-page":"100036","DOI":"10.1016\/j.xcrm.2020.100036","article-title":"Identification of SARS-CoV-2 vaccine epitopes predicted to induce long-term population-scale immunity","volume":"1","author":"Yarmarkovich","year":"2020","journal-title":"Cell Rep Med."},{"issue":"12","key":"10.1016\/j.intimp.2021.107439_b0425","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nrmicro3143","article-title":"A decade after SARS: strategies for controlling emerging coronaviruses","volume":"11","author":"Graham","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"issue":"4","key":"10.1016\/j.intimp.2021.107439_b0430","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.drudis.2020.01.015","article-title":"Recent discovery and development of inhibitors targeting coronaviruses","volume":"25","author":"Pillaiyar","year":"2020","journal-title":"Drug Discov Today."},{"issue":"6982","key":"10.1016\/j.intimp.2021.107439_b0435","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature02463","article-title":"A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice","volume":"428","author":"Yang","year":"2004","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.intimp.2021.107439_b0440","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3201\/eid1107.050219","article-title":"SARS vaccine development","volume":"11","author":"Jiang","year":"2005","journal-title":"Emerg. Infect. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2021.107439_b0445","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1080\/22221751.2019.1597644","article-title":"Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein","volume":"8","author":"Widjaja","year":"2019","journal-title":"Emerg. Microbes. Infect."},{"key":"10.1016\/j.intimp.2021.107439_b0450","doi-asserted-by":"crossref","first-page":"197834","DOI":"10.1016\/j.virusres.2019.197834","article-title":"Identification of the immunodominant neutralizing regions in the spike glycoprotein of porcine deltacoronavirus","volume":"276","author":"Chen","year":"2020","journal-title":"Virus Res."},{"issue":"7","key":"10.1016\/j.intimp.2021.107439_b0455","doi-asserted-by":"crossref","first-page":"e0220196","DOI":"10.1371\/journal.pone.0220196","article-title":"Superior immune responses induced by intranasal immunization with recombinant adenovirus-based vaccine expressing full-length Spike protein of Middle East respiratory syndrome coronavirus","volume":"14","author":"Kim","year":"2019","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.intimp.2021.107439_b0460","doi-asserted-by":"crossref","DOI":"10.3390\/v12010125","article-title":"Characterization of the immune response of MERS-CoV vaccine candidates derived from two different vectors in mice","volume":"12","author":"Li","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.intimp.2021.107439_b0465","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.antiviral.2016.11.006","article-title":"T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV","volume":"137","author":"Liu","year":"2017","journal-title":"Antiviral Res."},{"issue":"1","key":"10.1016\/j.intimp.2021.107439_b0470","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/22221751.2020.1723441","article-title":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies","volume":"9","author":"Jiang","year":"2020","journal-title":"Emerg Microbes Infect."},{"issue":"2","key":"10.1016\/j.intimp.2021.107439_b0475","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.micinf.2020.01.003","article-title":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China","volume":"22","author":"Yu","year":"2020","journal-title":"Microbes Infect."},{"issue":"5","key":"10.1016\/j.intimp.2021.107439_b0480","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/cbic.202000047","article-title":"Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV","volume":"21","author":"Morse","year":"2020","journal-title":"ChemBioChem"},{"issue":"4","key":"10.1016\/j.intimp.2021.107439_b0485","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1109\/TCBB.2017.2702588","article-title":"Analysis of the genome sequence and prediction of B-cell epitopes of the envelope protein of middle east respiratory syndrome-Coronavirus","volume":"15","author":"Xie","year":"2018","journal-title":"IEEE\/ACM Trans. Comput. Biol. Bioinform."},{"issue":"3","key":"10.1016\/j.intimp.2021.107439_b0490","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jinf.2005.04.010","article-title":"Proposal for vaccination against SARS coronavirus using avian infectious bronchitis virus strain H from The Netherlands","volume":"51","author":"Bijlenga","year":"2005","journal-title":"J. Infect."},{"issue":"5","key":"10.1016\/j.intimp.2021.107439_b0495","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/jmv.25707","article-title":"Potential interventions for novel coronavirus in China: a systematic review","volume":"92","author":"Zhang","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.intimp.2021.107439_b0500","doi-asserted-by":"crossref","first-page":"197863","DOI":"10.1016\/j.virusres.2020.197863","article-title":"Characterization of novel monoclonal antibodies against MERS-coronavirus spike protein","volume":"278","author":"Goo","year":"2020","journal-title":"Virus Res."},{"issue":"12","key":"10.1016\/j.intimp.2021.107439_b0505","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s11427-017-9189-3","article-title":"Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like coronaviruses","volume":"60","author":"Zeng","year":"2017","journal-title":"Sci. China Life Sci."},{"issue":"6477","key":"10.1016\/j.intimp.2021.107439_b0510","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1126\/science.367.6477.492","article-title":"New coronavirus threat galvanizes scientists","volume":"367","author":"Cohen","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.intimp.2021.107439_b0515","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41426-018-0031-3","article-title":"Human transbodies that interfere with the functions of Ebola virus VP35 protein in genome replication and transcription and innate immune antagonism","volume":"7","author":"Seesuay","year":"2018","journal-title":"Emerg. Microbes. Infect."},{"issue":"6","key":"10.1016\/j.intimp.2021.107439_b0520","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1080\/21645515.2020.1735227","article-title":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics","volume":"16","author":"Dhama","year":"2020","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.intimp.2021.107439_b0525","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.coviro.2015.06.009","article-title":"Animal models for SARS and MERS coronaviruses","volume":"13","author":"Gretebeck","year":"2015","journal-title":"Curr. Opin. Virol."},{"issue":"5","key":"10.1016\/j.intimp.2021.107439_b0530","first-page":"450","article-title":"Mice transgenic for human angiotensin-converting enzyme 2 provide a model for SARS coronavirus infection","volume":"57","author":"Yang","year":"2007","journal-title":"Comp. Med."},{"issue":"16","key":"10.1016\/j.intimp.2021.107439_b0535","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1056\/NEJMc1215691","article-title":"Pneumonia from human coronavirus in a macaque model","volume":"368","author":"Munster","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.intimp.2021.107439_b0540","doi-asserted-by":"crossref","first-page":"e1004250","DOI":"10.1371\/journal.ppat.1004250","article-title":"Infection with MERS-CoV causes lethal pneumonia in the common marmoset","volume":"10","author":"Falzarano","year":"2014","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.intimp.2021.107439_b0545","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.virusres.2007.03.025","article-title":"Animal models and vaccines for SARS-CoV infection","volume":"133","author":"Roberts","year":"2008","journal-title":"Virus Res."},{"issue":"8","key":"10.1016\/j.intimp.2021.107439_b0550","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/14760584.2018.1506702","article-title":"Prospects for a MERS-CoV spike vaccine","volume":"17","author":"Zhou","year":"2018","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.intimp.2021.107439_b0555","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.3389\/fmicb.2019.01781","article-title":"Recent advances in the vaccine development against middle east respiratory syndrome-coronavirus","volume":"10","author":"Yong","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.intimp.2021.107439_b0560","unstructured":"WHO. Draft landscape of COVID-19 candidate vaccines 2020. Available from: https:\/\/www.who.int\/publications\/m\/item\/draft-landscape-of-covid-19-candidate-vaccines."},{"issue":"3","key":"10.1016\/j.intimp.2021.107439_b0565","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1586\/14760584.2016.1124762","article-title":"Molecular mechanisms for enhanced DNA vaccine immunogenicity","volume":"15","author":"Li","year":"2016","journal-title":"Expert Rev. Vaccines"},{"issue":"3","key":"10.1016\/j.intimp.2021.107439_b0570","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/cid\/cir334","article-title":"Clinical applications of DNA vaccines: current progress","volume":"53","author":"Ferraro","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.intimp.2021.107439_b0575","unstructured":"Arena CT. Inovio commences Phase I trial of DNA vaccine for Covid-19 2020 [Available from: https:\/\/www.clinicaltrialsarena.com\/news\/inovio-SARS-COV-2-vaccine-trial\/urisimplehttps:\/\/www.clinicaltrialsarena.com\/news\/inovio-SARS-COV-2-vaccine-trial\/."},{"key":"10.1016\/j.intimp.2021.107439_b0580","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.virusres.2014.11.013","article-title":"Receptor-binding domain-based subunit vaccines against MERS-CoV","volume":"202","author":"Zhang","year":"2015","journal-title":"Virus Res."},{"issue":"1","key":"10.1016\/j.intimp.2021.107439_b0585","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7774\/cevr.2012.1.1.18","article-title":"A review of vaccine development and research for industry animals in Korea","volume":"1","author":"Lee","year":"2012","journal-title":"Clin. Exp. Vaccine Res."},{"key":"10.1016\/j.intimp.2021.107439_b0590","unstructured":"Arena CT. University of Oxford starts enrolment for Covid-19 vaccine trial 2020. Available from: https:\/\/www.clinicaltrialsarena.com\/news\/oxford-university-covid-19-vaccine-trial\/urisimplehttps:\/\/www.clinicaltrialsarena.com\/news\/oxford-university-covid-19-vaccine-trial\/."},{"key":"10.1016\/j.intimp.2021.107439_b0595","first-page":"327","article-title":"Virus like particles \u2013 a recent advancement in vaccine development","volume":"55","author":"Sarkar","year":"2019","journal-title":"Korean J. Microbiol."},{"key":"10.1016\/j.intimp.2021.107439_b0605","unstructured":"WHO, WHO, WHO2020."},{"key":"10.1016\/j.intimp.2021.107439_b0610","article-title":"Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18\u201359 years: a randomised, double-blind, placebo-controlled, phase 1\/2 clinical trial","author":"Zhang","year":"2020","journal-title":"Lancet Infect. Dis."},{"issue":"7830","key":"10.1016\/j.intimp.2021.107439_b0615","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41586-020-2639-4","article-title":"Phase I\/II study of COVID-19 RNA vaccine BNT162b1 in adults","volume":"586","author":"Mulligan","year":"2020","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.intimp.2021.107439_b0620","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA vaccine against SARS-CoV-2 - preliminary report","volume":"383","author":"Jackson","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"25","key":"10.1016\/j.intimp.2021.107439_b0625","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa2028436","article-title":"Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults","volume":"383","author":"Anderson","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.intimp.2021.107439_b0630","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.immuni.2020.03.007","article-title":"SARS-CoV-2 vaccines: status report","volume":"52","author":"Amanat","year":"2020","journal-title":"Immunity"},{"issue":"23","key":"10.1016\/j.intimp.2021.107439_b0635","doi-asserted-by":"crossref","first-page":"12201","DOI":"10.1128\/JVI.06048-11","article-title":"A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge","volume":"85","author":"Bolles","year":"2011","journal-title":"J. Virol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921000758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921000758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:29:12Z","timestamp":1761586152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921000758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":126,"alternative-id":["S1567576921000758"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107439","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune response scenario and vaccine development for SARS-CoV-2 infection","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107439","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107439"}}